SONENDO INC (SONX) 2.56 -0.04 (-1.54%)
2.56 -0.04 (-1.54%)
US8354311073 - Common Stock
Fundamental Rating
Overall SONX gets a fundamental rating of 3 out of 10. We evaluated SONX against 223 industry peers in the Health Care Equipment & Supplies industry. SONX scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. SONX is quite expensive at the moment. It does show a decent growth rate.
Note: SONX has only limited data available, so a full analysis was not possible, which makes the total rating unfair.
Profitability
Profitability Rating
SONX has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of SONX.
VS Industry
Valuation
Valuation Rating
When comparing the price book ratio of SONX to the average industry price book ratio of 2.90, SONX is valued rather cheaply.
When comparing the current price to the book value of SONX, we can conclude it is valued correctly. It is trading at 1.41 times its book value.
SONX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SONX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry
Price/Book (1.41) VS Industry: 73% outperformed.
1,369.61
0.21
Growth
Growth Rating
The Earnings Per Share is expected to grow by 17.97% on average over the next 5 years. This is quite good.
The Revenue has grown by 42.17% in the past year. This is a very strong growth!
The Revenue is expected to grow by 35.28% on average over the next 5 years. This is a very strong growth
SONX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.89%.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | -3.89% | 51.46% | 32.43% | 22.05% | 17.97% |
| Revenue | N/A | N/A | 42.17% | 26.62% | 29.57% | 36.08% | 35.28% |
Health
Health Rating
A Current Ratio of 8.86 indicates that SONX has no problem at all paying its short term obligations.
The Current Ratio of SONX is much better than the industry average of 3.69. SONX has a better rating than 86% of its industry peers.
A Quick Ratio of 7.80 indicates that SONX has no problem at all paying its short term obligations.
SONX is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.91. SONX has a better rating than 85% of its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.11, SONX is more dependent on financing than its industry peers.
SONX has an Altman-Z score of -2.13. This is a bad value and indicates that SONX is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of SONX to the average industry Altman-Z score of 1.97, SONX is less financially healthy than its industry peers.
SONX has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of SONX.
VS Industry
Debt/Equity (0.41) VS Industry: 32% outperformed.
336.87
0.00
Quick Ratio (7.8) VS Industry: 85% outperformed.
0.06
33.20
Current Ratio (8.86) VS Industry: 86% outperformed.
0.12
33.20
Altman-Z (-2.13) VS Industry: 32% outperformed.
-101.74
78.21
Dividend
Dividend Rating
No dividends for SONX!.
SONENDO INC2.56
NYSE:SONX (2/3/2023, 7:08:44 PM)-0.04 (-1.54%)
| GICS Sector | Health Care | ||
| GICS IndustryGroup | Health Care Equipment & Services | ||
| GICS Industry | Health Care Equipment & Supplies | ||
| Earnings (Last) | 11-09 2022-11-09/amc | Earnings (Next) | N/A N/A |
| Inst Owners | N/A | Inst Owner Change | N/A |
| Ins Owners | 5.34% | Ins Owner Change | -1.46% |
| Market Cap | 127.38M | Analysts | 83.64 |
| Price Target | 3.52 (37.5%) | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Dividend Growth(5Y) | N/A | DP | N/A |
| Div Incr Years | N/A | Div Non Decr Years | N/A |
| Ex-Date | N/A | ||
| EPS beat(2) | N/A | Avg EPS beat(2) | -4.46% |
| Min EPS beat(2) | -8.42% | Max EPS beat(2) | -0.51% |
| EPS beat(4) | N/A | Avg EPS beat(4) | -14.01% |
| Min EPS beat(4) | -41.18% | Max EPS beat(4) | -0.51% |
| Revenue beat(2) | 2 | Avg Revenue beat(2) | 2.92% |
| Min Revenue beat(2) | 2.15% | Max Revenue beat(2) | 3.69% |
| Revenue beat(4) | 4 | Avg Revenue beat(4) | 4.63% |
| Min Revenue beat(4) | 2.15% | Max Revenue beat(4) | 7.72% |
| PT rev (1m) | -5.99% | PT rev (3m) | -21.23% |
| EPS NQ rev (1m) | 0% | EPS NQ rev (3m) | 25.54% |
| EPS NY rev (1m) | 0% | EPS NY rev (3m) | -0.11% |
| Revenue NQ rev (1m) | 0% | Revenue NQ rev (3m) | -3.78% |
| Revenue NY rev (1m) | 0% | Revenue NY rev (3m) | -0.22% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.24 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.41 | ||
| P/tB | 1.6 | ||
| EV/EBITDA | N/A |
| EPS(TTM) | -2.35 | EY | N/A |
| EPS(NY) | -0.77 | Fwd EY | N/A |
| FCF(TTM) | -1.26 | FCFY | N/A |
| OCF(TTM) | -1.24 | OCFY | N/A |
| SpS | 0.79 | BVpS | 1.82 |
| TBVpS | 1.6 | PEG (NY) | N/A |
| PEG (5Y) | N/A | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM | N/A | ||
| GM | 24.42% |
| ROICexgc(3y) | N/A | ROICexcg growth 3Y | N/A |
| ROICexcg growth 5Y | N/A | ROICexc(3y) | N/A |
| ROICexc growth 3Y | N/A | ROICexc growth 5Y | N/A |
| OM growth 3Y | N/A | OM growth 5Y | N/A |
| PM growth 3Y | N/A | PM growth 5Y | N/A |
| GM growth 3Y | N/A | GM growth 5Y | N/A |
| F-Score | 3 | Asset Turnover | 0.28 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 70.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 8.86 | ||
| Quick Ratio | 7.8 | ||
| Altman-Z | -2.13 |
| F-Score | 3 | WACC | 10.39% |
| ROIC/WACC | N/A | Cap/Depr(3y) | 82.4% |
| Cap/Depr(5y) | N/A | Profit Quality(3y) | N/A |
| Profit Quality(5y) | N/A | ||
| EPS 1Y | -3.89% | EPS 3Y | N/A |
| EPS 5Y | N/A | EPS growth Q2Q | 95.45% |
| EPS Next Y | 51.46% | EPS Next 2Y | 32.43% |
| EPS Next 3Y | 22.05% | EPS Next 5Y | 17.97% |
| Revenue growth 1Y | 42.17% | Revenue growth 3Y | N/A |
| Revenue growth 5Y | N/A | Revenue growth Q2Q | 24.84% |
| Revenue Next Year | 26.62% | Revenue Next 2Y | 29.57% |
| Revenue Next 3Y | 36.08% | Revenue Next 5Y | 35.28% |
| EBIT growth 1Y | -3.76% | EBIT growth 3Y | N/A |
| EBIT growth 5Y | N/A | EBIT Next Year | -13.9% |
| EBIT Next 3Y | 9.14% | EBIT Next 5Y | 16.08% |
| FCF growth 1Y | -28.18% | FCF growth 3Y | N/A |
| FCF growth 5Y | N/A | OCF growth 1Y | -26.1% |
| OCF growth 3Y | N/A | OCF growth 5Y | N/A |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA